J
JNJ
Johnson & Johnson
238.41
-2.56-1.06%After Hours: 240.23 +1.82 +0.76%18:46 04/07 EDT
OPEN/PREV CLOSE240.78/240.97
TODAY RANGE236.01-240.78
VOL6.23M
MARKET CAP574.24B
52 WEEK RANGE137.66-251.71
AVG VOL (3M)8.78M
% TURNOVER0.26%
TURNOVER--
P/E (TTM)21.61
% RANGE1.98%
EPS(TTM)11.03
P/E(FORWARD)24.44
P/B7.04
BVPS33.86
DIVIDEND5.20
P/S6.09
BETA--
DIV YIELD2.18%
FREE FLOAT MKT CAP573.81B
SHARES OUTSTANDING2.41B
NEXT EARNINGS04/16-04/22
FREE FLOAT2.41B
LOT SIZE1
EX-DATE02/24/2026
News
Press Releases
Financial Reports
Profile
Benzinga·6h ago
Microsoft Is Now The Biggest Deadweight On S&P 500 — And Exxon Is What Nvidia Used To Be
Seeking Alpha·8h ago
Vertex Pharma in pact with Halozyme for Hypercon drug delivery tech
TipRanks·10h ago
Johnson & Johnson announces launch of Varipulse Pro in Europe
TipRanks·11h ago
Johnson & Johnson price target raised to $285 from $274 at Citi
Seeking Alpha·1d ago
Safe Stocks Exist, You're Just Looking In The Wrong Places
Simply Wall St·1d ago
ICOTYDE Psoriasis Data And JNJ-4804 Funding Could Be A Game Changer For Johnson & Johnson (JNJ)
Simply Wall St·2d ago
Assessing Johnson & Johnson (JNJ) Valuation After Autoimmune Pipeline Advances And New R&D Partnership
Seeking Alpha·3d ago
Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030
Simply Wall St·3d ago
Johnson And Johnson Expands Sirturo Reach In Japan With KYORIN Deal
TipRanks·4d ago
Erste Group Remains a Buy on Johnson & Johnson (JNJ)
Same Industry
Name/Symbol
Change%
Price